Implant Sciences Receives Additional Orders for QS-H150 Explosives Detectors
Implant Sciences zu myNews hinzufügen Was ist das?
Implant Sciences Corporation (AMEX: IMX), a high technology
supplier of systems and sensors for the homeland security market and
related industries, today announced new orders totaling more than
$4,200,000 for its Quantum SnifferTM QS-H150
portable explosives detectors. The units are to be delivered to
distributors and customers in Asia and Europe.
"Our sales team continues to work very hard
with our various distributors and customers, resulting in an all-time
high for orders of our security products,”
stated Phillip C. Thomas, President and CEO of Implant Sciences. "Combined
with the $2.7 million in orders announced in our May 29th
press release, we have received more than $7.0 million of new business
during the past 60 days.”
Mr. Thomas added, "One of our ongoing
objectives has been to increase sales from existing customers while also
adding new geographic locations where we do business. This has been
facilitated by recently obtaining the CE mark on the H-150 which has
opened the door to sales in locations where that certification is a
requirement. These new orders are a partial fulfillment of our
diversification goal as we are beginning to see expanded use of our
products to help meet security needs in various countries. It should be
noted that while we are pleased with these new orders, we recognize much
of the volume is being driven by international events in Asia that are
somewhat time dependent. Thus, we expect these volumes may not
necessarily be sustainable. However, we are encouraged by the growth of
the product line in Asia and the corresponding widening of our
distribution efforts resulting in further sales in Europe, both of which
could have a positive impact on future demand.”
The QS-H150 provides high performance and reliability in the detection
and recognition of a wide range of trace amounts of explosives combined
with a low total cost of ownership. Annual maintenance requirements are
minimal and consist primarily of normal care and cleaning using common
supplies. Unlike some competitive units, calibration is autonomous,
continuous, and requires virtually no consumables. Furthermore, since
there are no radioactive materials used in the QS-H150, there are no
associated certifications, licenses, inspections, or end-of-life
disposal issues. As such, customers have a cost-effective product
available to them that can perform in a wide range of environments in
support of efforts to improve their overall security profile and meet
mission critical objectives.
About Implant Sciences
Implant Sciences develops, manufactures and sells sophisticated sensors
and systems for the Security, Safety and Defense (SS&D) industries. The
Company has developed proprietary technologies used in its commercial
portable and bench-top explosive trace detection systems which ship to a
growing number of locations domestically and internationally. For
further details on the Company and its products, please visit the Company’s
website at www.implantsciences.com.
Safe Harbor Statement
This press release contains certain "forward-looking
statements,” as that term is defined in the
Private Securities Litigation Reform Act of 1995. Such statements are
based on management’s current expectations
and are subject to risks and uncertainties that could cause the Company’s
actual results to differ materially from the forward-looking statements.
Such risks and uncertainties include, but are not limited to, the Company’s
ability to successfully ship sufficient quantities of H-150 explosives
detection equipment to meet the orders received, continued solicitation
of orders for the sale of additional equipment in Asia, Europe, and
other international locations, sustainability of these order volumes in
the future and other risks and uncertainties described in the Company’s
filings with the Securities and Exchange Commission, including its most
recent Forms 10-K, 10-Q and 8-K.
For further information, you are encouraged to review Implant Sciences’
filings with the Securities and Exchange Commission, including its
Annual Report on Form 10-K for the period ended June 30, 2007 and
Quarterly Reports for the periods ended September 30, 2007, December 31,
2007 and March 31, 2008. The Company assumes no obligation to update the
information contained in this press release.